| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.0086 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0083 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |